Project Grant R21AA031708

Award Date 9/26/24
Completion Date 8/31/26
Dollars Obligated $221K
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
This Project Grant from the Department of Health and Human Services' National Institutes of Health National Institute on Alcohol Abuse and Alcoholism funded $160,462.52 to Oregon Health & Science University from June 1, 2021 through July 16, 2021 under the Alcohol Research Programs (CFDA 93.273) federal grant program. The grant funding supported research to test the hypothesis that chronic alcohol use leads to aberrant steroid secretion and differential DNA methylation in the adrenal...
This Project Grant award, funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program, aims to investigate the neural mechanisms driving adaptive stress coping behaviors and subsequent alcohol use. The $498,121.57 award, effective August 15, 2024 through July 31, 2027, will utilize an animal model to explore how dysfunction in the corticolimbic circuitry, specifically the prelimbic cortex and basolateral...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) grant program, will support research to investigate the role of sex chromosomes in alcohol drinking behaviors. The total award amount is $321,102 and the project will run from August 1, 2024 to July 31, 2029. The key objectives of the research are to: 1) demonstrate that alcohol consumption is reduced in mice with two X chromosomes compared to...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) program, is providing $1,010,019 to Pennsylvania State University to conduct research on the relationship between the vagus nerve, hypothalamic neurocircuits, and alcohol intake. The key objectives are to: 1) Test the hypothesis that disruptions to the gastric vagus nerve activity will increase alcohol reward and preference, and alter gene...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) program, provides $499,442 in funding to The Regents of the University of California, San Francisco (UCSF) from August 20, 2024 through July 31, 2027. The award supports research to investigate the role of brain-derived neurotrophic factor (BDNF) signaling in the ventral hippocampus and its contribution to the acute anxiolytic and social...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a Project Grant under the Alcohol Research Programs (CFDA 93.273) to The Johns Hopkins University in the amount of $807,050 on August 20, 2024. The grant will fund a research project examining the neural circuit effects of chronic alcohol use on cognition and behavior in rodent models. The key objectives are to: 1) Characterize changes in neural activity within the anterior cingulate cortex, orbitofrontal cortex, and...
This Project Grant award in the amount of $404,508.00 was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award aims to examine interleukin-1β (IL-1β) synaptic regulation and its role in cognitive impairment during early withdrawal and protracted abstinence from chronic alcohol exposure in male and female mice. The overarching goal is to determine the neuroimmune mechanisms by which chronic...
This Project Grant award of $594,784 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund a postmortem, multi-omic study of brains from 341 total subjects to identify novel lasting transcriptomic and epigenetic changes in biological pathways that may serve as biomarkers and therapeutic targets for alcohol use disorder (AUD). The research will analyze RNA sequencing and whole-genome bisulfite sequencing data across 8 brain...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $194,551 Project Grant under the Alcohol Research Programs (CFDA 93.273) to The Medical University of South Carolina. The funding supports research to investigate the effects of adolescent intermittent ethanol exposure on the regulation of a neural pathway involving the prelimbic cortex and ventrolateral periaqueductal gray, and its impact on pain processing and sensitivity. The research aims to elucidate how changes in the...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will support the development and testing of a novel in vivo model called CHIMERA-BONCAT. This model will enable comprehensive, unbiased, and cell-type-specific characterization of the human microglial response to alcohol exposure. The $214,385 award, with a period of performance from August 2024 to July 2026, will fund research...

This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will provide $221,375 to Oregon Health & Science University (OHSU) to investigate the role of the anterior olfactory system in regulating alcohol consumption.

The key objectives are to examine whether chemogenetic activation of oxytocin receptor (OXTR)-containing neurons in the anterior olfactory nucleus (AON) and vasopressin receptor 1A (AVPR1A)-containing neurons in the main olfactory bulb (MOB) can modulate alcohol consumption in male and female mice. The project will also evaluate whether the anterior olfactory OXTR and AVPR1A contribute to oxytocin's inhibitory effects on alcohol intake through region-selective conditional deletion of OXTR. These experiments aim to provide a foundation for understanding the mechanisms by which the olfactory system may be targeted for the treatment of alcohol use disorder. The award period is from Sep 26, 2024 to Aug 31, 2026.

Generated 7/1/25, 1:55 AM